Editor’s highlights from the Journal of Comparative Effectiveness Research – May 2020

Written by Laura Dormer, Editor

In this latest instalment of her regular column, Editorial Director, Laura Dormer, shares some of her highlights from the latest issues of the Journal of Comparative Effectiveness Research. Welcome to this month’s round-up of some of the recently published articles in the Journal of Comparative Effectiveness Research! Although I sadly could not see you at the ISPOR Annual Meeting as I usually would have this month, I hope all our readers are keeping safe and well, and enjoy the article highlights I’ve picked out from the May issue — happy reading!  Although both eltrombopag and romiplostim are US FDA-approved therapies...

To view this content, please register now for access

It's completely free